Barinthus Biotherapeutics plc
BRNS
$0.839
$0.0161.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.12% | -33.81% | -31.93% | -32.07% | -26.90% |
| Total Receivables | -10.08% | 256.88% | 62.54% | 85.76% | -34.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.46% | 56.63% | 15.54% | -3.80% | -8.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 41.25% | 30.70% | -58.24% | 178.24% | 141.24% |
| Total Current Assets | -19.86% | -21.28% | -28.63% | -28.67% | -26.35% |
|
|
|||||
| Total Current Assets | -19.86% | -21.28% | -28.63% | -28.67% | -26.35% |
| Net Property, Plant & Equipment | -39.40% | -8.00% | -14.92% | -7.32% | 23.50% |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -12.59% | -12.21% | -11.84% | -11.51% | -11.18% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.11% | -12.23% | -11.93% | -13.91% | -9.63% |
| Total Assets | -25.26% | -17.95% | -24.13% | -23.81% | -20.61% |
|
|
|||||
| Total Accounts Payable | 54.53% | -40.21% | 5.23% | -73.15% | -57.28% |
| Total Accrued Expenses | 3.40% | -33.19% | 20.25% | 42.42% | 14.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.56% | 32.31% | 68.81% | 194.14% | 312.24% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 23.30% | -- |
| Total Other Current Liabilities | -- | -- | -- | 23.30% | -- |
| Total Current Liabilities | 24.28% | -18.83% | 28.72% | 7.07% | 2.91% |
|
|
|||||
| Total Current Liabilities | 24.28% | -18.83% | 28.72% | 7.07% | 2.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.87% | -4.63% | -3.53% | 8.92% | 34.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.51% | -24.43% | -32.57% | -40.29% | -42.04% |
| Total Liabilities | 9.75% | -14.95% | 4.51% | -2.76% | 1.88% |
|
|
|||||
| Common Stock & APIC | 1.78% | 1.60% | 1.20% | 1.36% | 1.87% |
| Retained Earnings | -34.59% | -36.30% | -43.92% | -58.19% | -71.04% |
| Treasury Stock & Other | -10.99% | 50.13% | -6.22% | 13.86% | 30.38% |
| Total Common Equity | -30.39% | -18.48% | -27.90% | -26.35% | -23.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.39% | -18.48% | -27.90% | -26.35% | -23.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -49.76% | -18.54% | -32.02% | -31.72% | -30.82% |
| Total Equity | -30.41% | -18.48% | -27.90% | -26.35% | -23.11% |
|
|
|||||